Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-29 @ 11:30 PM
Study NCT ID:
NCT06918132
Status:
RECRUITING
Last Update Posted:
2025-12-12
First Post:
2025-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-29
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-31
First Submit QC Date:
None
Study First Post Date:
2025-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-12
Last Update Post Date Type:
ESTIMATED